DBN1 and breast carcinoma: For the mutome genes, the integrative analysis of genomic copy number and expression data strongly indicates that DBN1 is a candidate oncogene that, when highly expressed in tumors with respect to healthy tissues, predicts poor survival in breast cancer patients (Fig. 3).